title: Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
authors.forename: Sundeep
authors.initials: S
authors.lastname: Khosla
authors.forename: David
authors.initials: D
authors.lastname: Burr
authors.forename: Jane
authors.initials: J
authors.lastname: Cauley
authors.forename: David W
authors.initials: DW
authors.lastname: Dempster
authors.forename: Peter R
authors.initials: PR
authors.lastname: Ebeling
authors.forename: Dieter
authors.initials: D
authors.lastname: Felsenberg
authors.forename: Robert F
authors.initials: RF
authors.lastname: Gagel
authors.forename: Vincente
authors.initials: V
authors.lastname: Gilsanz
authors.forename: Theresa
authors.initials: T
authors.lastname: Guise
authors.forename: Sreenivas
authors.initials: S
authors.lastname: Koka
authors.forename: Laurie K
authors.initials: LK
authors.lastname: McCauley
authors.forename: Joan
authors.initials: J
authors.lastname: McGowan
authors.forename: Marc D
authors.initials: MD
authors.lastname: McKee
authors.forename: Suresh
authors.initials: S
authors.lastname: Mohla
authors.forename: David G
authors.initials: DG
authors.lastname: Pendrys
authors.forename: Lawrence G
authors.initials: LG
authors.lastname: Raisz
authors.forename: Salvatore L
authors.initials: SL
authors.lastname: Ruggiero
authors.forename: David M
authors.initials: DM
authors.lastname: Shafer
authors.forename: Lillian
authors.initials: L
authors.lastname: Shum
authors.forename: Stuart L
authors.initials: SL
authors.lastname: Silverman
authors.forename: Catherine H
authors.initials: CH
authors.lastname: Van Poznak
authors.forename: Nelson
authors.initials: N
authors.lastname: Watts
authors.forename: Sook-Bin
authors.initials: SB
authors.lastname: Woo
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Shane
mesh_terms: D000284:Administration, Oral; D015415:Biomarkers / Q000097:blood; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D024042:Collagen Type I / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007571:Jaw Diseases / Q000097:blood* / Q000139:chemically induced; D010020:Osteonecrosis / Q000097:blood* / Q000139:chemically induced; D010455:Peptides / Q000097:blood; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D004164:Diphosphonates; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide